Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

07. Août 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1972


	Articles 1 - 20 / 39436

	Comparative efficacy and outcomes of different treatments for pathologically high-risk superficial esophageal cancer: a systematic review and network meta-analysis. Front Oncol He H, Zhang H, Lv H, Ding N, Wang W. PMID: 42564051 [PubMed]
	External validation of a prognostic score for oesophageal cancer (PSOC) for patients treated with palliative intent in a resource-limited setting. S Afr Med J Ferndale L, Bhadree S, Chen WC. PMID: 42563653 [PubMed - indexed for MEDLINE]
	Dynamic iterative coarse-to-fine prompt learning based on SAM for precise esophageal cancer gross target volume segmentation. Phys Med Biol Yao Y, Sun H, Chen C, Liu T, Zhang W, Wang Q, Liu Y, Zhao L, Huang D. PMID: 42561998 [PubMed - as supplied by publisher]
	Artificial Intelligence/Machine Learning-Driven cfDNA Methylation Blood Test for Early Cancer Detection in Military Personnel With Environmental Toxin Exposure. Mil Med Subharam M, Koehler R, Sreedhar T. PMID: 42560195 [PubMed - indexed for MEDLINE]
	Reply to: Comments on "Meat Intake and Risk of Gastric and Esophageal Adenocarcinoma in the European Prospective Investigation Into Cancer and Nutrition (EPIC)Â Study". Int J Cancer Bonet C, Agudo A, Jakszyn P. PMID: 42559710 [PubMed - as supplied by publisher]
	Transthoracic versus Transhiatal Esophagectomy for Esophageal Squamous Cell Carcinoma. JSLS Gunes A, Akay O, Ozdamar M, Guler M, Yazicioglu MB, Yuksel A, Tiryaki C. PMID: 42559527 [PubMed - indexed for MEDLINE]
	Predictive performance of the Modified Frailty Index and ASA-PS classification for 30-day mortality after esophagectomy in patients with esophageal cancer. Front Oncol Chaochankit W, Sunpaweravong S, Sungworawongpana C. PMID: 42558418 [PubMed]
	Comments on "Meat Intake and Risk of Gastric and Esophageal Adenocarcinoma in the European Prospective Investigation Into Cancer and Nutrition (EPIC) Study". Int J Cancer Sun M, Zang D, Chen J. PMID: 42557996 [PubMed - as supplied by publisher]
	Is Pyloroplasty Necessary During Esophagectomy? Review of Literature and Technical Considerations. Adv Surg Christie IG, Alicuben ET, Pennathur A, Luketich S, Luketich JD. PMID: 42556952 [PubMed - indexed for MEDLINE]
	CT-derived myosteatosis as a predictor of postoperative outcomes in esophagogastric cancer surgery: a systematic review. Front Med (Lausanne) Rondovic G, Sarac M, Lekovic I, Maric N, Sarac S, Stamenkovic D, Stojanovic M, Bojic S. PMID: 42553334 [PubMed]
	Prognostic analysis of first-recurrence/metastasis esophageal squamous cell carcinoma: chemoimmunotherapy combined with radiotherapy as one of the optimal clinical management strategies. Front Immunol Li Y, Li Q, Wang K, Gao M, Tian L, Liu M, Bu Y, Cui Y. PMID: 42553314 [PubMed - indexed for MEDLINE]
	Medical information and decision-making in palliative cancer: a qualitative study of patients' perceptions, needs, and preferences regarding physician communication. BMC Palliat Care Roick J, Heise C, Lambrecht N, Michl P, Porzelle J, Rauschenberg S, Reinacher-Schick A, Rosenau H, Schildmann J, Schneider T, Schulmann K, Sommerlatte S, Richter M. PMID: 42552529 [PubMed - indexed for MEDLINE]
	Social genomics and cancer - untangling nature from nurture in squamous cell carcinoma outcomes. Front Oncol Rahimabad PK, Shaban-Nejad A, Davis R, Hayes DN, Makowski L, Schwartz DL. PMID: 42548724 [PubMed]
	Bridging the gap: modern pharyngolaryngoesophagectomy techniques and the rise of neoadjuvant/immunotherapy approaches. World J Surg Oncol Nteka F, Triantafyllou T, Rouvelas I, Gkoutziotis I, Sakarellos P, Tolia M, Karavokyros I, Mpallas K, Schizas D. PMID: 42547869 [PubMed - indexed for MEDLINE]
	Winning the battle against Barrett esophagus and esophageal adenocarcinoma. Cleve Clin J Med Katzka DA. PMID: 42547280 [PubMed - indexed for MEDLINE]
	Development of an Esophageal Cancer-specific Nutrition Impact Symptom Scale for Individualized Postoperative Nutritional Nursing. J Vis Exp Cai S, Fu W. PMID: 42545907 [PubMed - indexed for MEDLINE]
	A single-arm phase III trial evaluating the non-inferiority of less-intensive surveillance for early gastric cancer: JCOG2504 (less-surveillance EGC). Jpn J Clin Oncol Kawabata K, Hayashi T, Makuuchi R, Yamada T, Yokoyama M, Uozumi T, Mitome N, Fukuda H, Kurokawa Y, Boku N, Yoshikawa T. PMID: 42545799 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Neoadjuvant Chemoimmunotherapy Versus Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis. Ann Surg Oncol Xu Y, Liang Y, Gao W, Yang X, Qin F, Tao Z, Li X, Chen K, Liang Y. PMID: 42545420 [PubMed - as supplied by publisher]
	Oligometastatic esophageal squamous cell carcinoma: a systematic review of current definitions and meta-analysis of local therapy outcomes. Dis Esophagus Nomura M, Bronzwaer SFC, Kroese TE, van Rossum PSN, Ruurda JP, van Hillegersberg R, Kato K, Ogata T, Kanda M, Hamai Y, Tsubosa Y, Yoshii T, Furuta M, Sakanaka K, Matsuda S, Tsushima T, Laarhoven HWM, Takeuchi H. PMID: 42544486 [PubMed - indexed for MEDLINE]
	Tumor-microenvironment-mediated immune escape drives trastuzumab resistance in HER2-positive gastric cancer. Gastroenterol Rep (Oxf) Lv H, Zhao W, Wang SQ, He Y, Nie C, Chen XB. PMID: 42542713 [PubMed]

Articles 1 - 20 / 39436

Page 1 de 1972



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité